Zobrazeno 1 - 10
of 257
pro vyhledávání: '"Jean-Michel Cayuela"'
Autor:
Romain Stammler, Maxime Battistella, Julien Calvani, Baptiste Louveau, François Lemonnier, Saskia Ingen‐Housz Oro, Nicolas Ortonne, Jean David Bouaziz, Jacqueline Rivet, Marie‐Dominique Vignon‐Pennamen, David Boutboul, Caroline Ram‐Wolff, Lionel Galicier, Catherine Thieblemont, Pauline Brice, Loïc Renaud, Geraldine Jeudy, Marie Beylot‐Barry, Christian Le Clech, Charlée Nardin, Jean‐Michel Cayuela, Véronique Meignin, Samia Mourah, Martine Bagot, Adèle De Masson, French Study Group on Cutaneous Lymphomas
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 727-738 (2023)
Abstract Background Angioimmunoblastic T‐cell lymphoma (AITL) is one of the most frequent peripheral T‐cell lymphomas (PTCL) in western countries. Skin involvement is common and may reveal the malignancy. Despite its frequency, skin involvement i
Externí odkaz:
https://doaj.org/article/79fbfa01aca74cc4b5bb5c4b6491f16f
Autor:
Andy Li, Jacqueline Lehmann‐Che, Jérôme Champ, Jacqueline Rivet, Marie‐Dominique Vignon‐Pennamen, Samia Mourah, Jean‐Michel Cayuela, Clémence Lepelletier, Baptiste Louveau, Maëlle Dumont, Jana Alhage, Caroline Ram‐Wolff, Jean‐David Bouaziz, Martine Bagot, Adèle De Masson, Maxime Battistella
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 3, Pp 625-628 (2023)
Abstract Primary cutaneous follicle centre lymphomas (PCFCLs) are cutaneous proliferation of centrocytes and centroblasts, with a generally indolent evolution. Secondary systemic spread of disease is a rare event, which significantly impairs prognosi
Externí odkaz:
https://doaj.org/article/3f374d0ea7314756a34b70fcfb8c0d3e
Autor:
Heriberto Bruzzoni-Giovanelli, Habib Zouali, Mourad Sahbatou, Benjamin Maneglier, Jean-Michel Cayuela, Angelita Rebollo, Gustavo H. Marin, Daniela Geromin, Carole Tomczak, Antonio Alberdi, Jean-Francois Deleuze, Philippe Rousselot
Publikováno v:
Pharmaceutics, Vol 16, Iss 6, p 834 (2024)
The tyrosine kinase Inhibitor (TKI) imatinib is approved for the treatment of the chronic phase of chronic myeloid leukemia (CP-CML). Pharmacokinetic studies have highlighted the importance of inter-patient variability on imatinib plasma trough conce
Externí odkaz:
https://doaj.org/article/af0adb86bb494509a40f152399bc276b
Autor:
Meryl Darlington, Pierre Sujobert, Olivier Kosmider, Damien Luque Paz, Sophie Kaltenbach, Martin Figeac, Sandrine Hayette, Nadia Mezaour, Séverine Coquerelle, Anne-Sophie Alary, Audrey Bidet, Yannick Le Bris, Eric Delabesse, Frédéric Davi, Claude Preudhomme, Isabelle Durand-Zaleski, Elizabeth Macintyre, Mélissa Alame, Fanny Baran-Marzak, Marc G. Berger, Dominique Bories, Aurélie Caye-Eude, Jean-Michel Cayuela, Pascale Cornillet-Lefebvre, François Delhommeau, Marie-Hélène Estienne-Felix, Pascaline Etancelin, Pascale Flandrin-Gresta, Eric Lippert, Christophe Marzac, Laurent Miguet, Cédric Pastoret, Sophie Raynaud, David Rizzo
Publikováno v:
HemaSphere, Vol 7, Iss 9, p e943 (2023)
The objective of this study was to assess the clinical impact and financial costs of next-generation sequencing (NGS) in 5 categories of pediatric and adult hematological cancers. NGS prescriptions were prospectively collected from 26 laboratories, w
Externí odkaz:
https://doaj.org/article/5186f41fd724486a8f7ea01350b38f70
Autor:
Thomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, Aurore Touzart, Mathieu Simonin, Johanna Mondesir, Ludovic Lhermitte, Jonathan Bond, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Marie Balsat, Norbert Vey, Elizabeth Macintyre, Norbert Ifrah, Hervé Dombret, Arnaud Petit, André Baruchel, Philippe Ruminy, Nicolas Boissel, Vahid Asnafi
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatme
Externí odkaz:
https://doaj.org/article/c899cfc57fba4ffba0873e05dddf4ebb
Autor:
Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Frédéric Bauduer, Kaddour Chabane, Patrice Chevallier, Pascale Cony-Makhoul, Pascale Flandrin-Gresta, Caroline Le Jeune, Yannick Le Bris, Laurence Legros, Hervé Maisonneuve, Lydia Roy, Francois-Xavier Mahon, Ivan Sloma, Delphine Rea, Franck Emmanuel Nicolini
Publikováno v:
Haematologica, Vol 107, Iss 12 (2022)
Externí odkaz:
https://doaj.org/article/948a36bc449e433f8635a69bf0a66dd6
Autor:
Mathieu Simonin, Aline Schmidt, Christophe Bontoux, Marie-Émilie Dourthe, Etienne Lengliné, Guillaume P. Andrieu, Ludovic Lhermitte, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Isabelle Arnoux, Stéphane Ducassou, Elizabeth Macintyre, Virginie Gandemer, Hervé Dombret, Arnaud Petit, Norbert Ifrah, André Baruchel, Nicolas Boissel, Vahid Asnafi
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-7 (2021)
Abstract IDH1 and IDH2 mutations (IDH1/2 Mut ) are recognized as recurrent genetic alterations in acute myeloid leukemia (AML) and associated with both clinical impact and therapeutic opportunity due to the recent development of specific IDH1/2 Mut i
Externí odkaz:
https://doaj.org/article/7cee1af54e584d0d9ef8464967937b4d
Autor:
Jeannig Berrou, Mélanie Dupont, Hanane Djamai, Emilie Adicéam, Véronique Parietti, Anna Kaci, Emmanuelle Clappier, Jean-Michel Cayuela, André Baruchel, Fabrice Paublant, Renaud Prudent, Jacques Ghysdael, Claude Gardin, Hervé Dombret, Thorsten Braun
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 22, p 6761 (2022)
Ph+ (BCR::ABL+) B-ALL was considered to be high risk, but recent advances in BCR::ABL-targeting TKIs has shown improved outcomes in combination with backbone chemotherapy. Nevertheless, new treatment strategies are needed, including approaches withou
Externí odkaz:
https://doaj.org/article/b8ef5dd2b6894ca7b53f74bb99898a4a
Autor:
Hyacinthe Johnson-Ansah, Benjamin Maneglier, Françoise Huguet, Laurence Legros, Martine Escoffre-Barbe, Martine Gardembas, Pascale Cony-Makhoul, Valérie Coiteux, Laurent Sutton, Wajed Abarah, Camille Pouaty, Jean-Michel Pignon, Bachra Choufi, Sorin Visanica, Bénédicte Deau, Laure Morisset, Emilie Cayssials, Mathieu Molimard, Stéphane Bouchet, François-Xavier Mahon, Franck Nicolini, Philippe Aegerter, Jean-Michel Cayuela, Marc Delord, Heriberto Bruzzoni-Giovanelli, Philippe Rousselot
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1676 (2022)
The registered dose for imatinib is 400 mg/d, despite high inter-patient variability in imatinib plasmatic exposure. Therapeutic drug monitoring (TDM) is routinely used to maximize a drug’s efficacy or tolerance. We decided to conduct a prospective
Externí odkaz:
https://doaj.org/article/133d20dc3fef461aa82f821be11325df
Autor:
Nicolas Guillaume, Pascale Loiseau, Katia Gagne, Hélène Moins-Teissserenc, Jean-Michel Cayuela, Guylaine Henry, Marie Robin, Régis Peffault de Latour, Eliane Gluckman, Gérard Socié, Christelle Retiere, Nicolas Dulphy, Antoine Toubert
Publikováno v:
Haematologica, Vol 101, Iss 5 (2016)
Externí odkaz:
https://doaj.org/article/1713199ac0ab4f78aceeeab7e55377a6